What's new on ICE?
DISCLAIMER: These news articles have been reproduced verbatim as on the original site, with the exception of replacing certain terms with United Nations terminology when necessary. As such, the articles are provided for general reference purposes. Their content does not imply official endorsement or acceptance by the United Nations.
- Las primeras NSP notificadas en 2023 muestran un fuerte aumento de los opioides sintéticos a medida que se diversifican los estimulantes y los cannabinoides sintéticos
- April 2024 - First reported NPS in 2023 show strong increase in synthetic opioids as stimulants and synthetic cannabinoids diversify
- Marzo de 2024 – UNODC: Cinco NSP "enlistadas" en la 67a Sesión de la Comisión de Estupefacientes
- March 2024 – UNODC: Five NPS "scheduled" at the 67th Session of the Commission on Narcotic Drugs
- Febrero de 2024 – SAT de UNODC: Nitazenos – surge un nuevo grupo de opioides sintéticos
- February 2024 – UNODC EWA: Nitazenes – a new group of synthetic opioids emerges
- Diciembre de 2023 – OMS: La Organización Mundial de la Salud recomienda cinco NSP para ser enlistadas
- December 2023 – WHO: World Health Organization recommends five NPS for scheduling
- Noviembre de 2023 - UNODC: entra en vigor la decisión de la CND sobre el control internacional de ADB-BUTINACA, alfa-PiHP y 3-metilmetcatinona
- November 2023 - UNODC: CND decision on international control of ADB-BUTINACA, alpha-PiHP and 3-methylmethcathinone enters into force
The IQAP International Collaborative Exercises (ICE) programme is aimed at helping drug-testing laboratories worldwide assess their own performance and take corrective actions, when appropriate. The ICE programme has two groups:
- The Seized Materials Group: The test samples in this group contain controlled drugs from actual seizures.
- Biological Specimens Group: The test samples in this group contain controlled drugs and their metabolites in freeze-dried human urine.